Pregnant Pause? Not for IBD Care-A Single Tertiary Care Center Prospective Cohort Study Affirming IBD Management in Pregnancy.

The use of oral 5-ASA alone showed an increasing trend, beginning at 18.9% preconception and rising consistently to 24.6% postpartum ( P < .001, Cochran’s Q = 16.056).

also in 28,909 other papers

Maternal adverse outcomes were less common among those with UC, with a trend toward significance (OR 0.583, 95% CI 0.310-1.097), and those age 40 or older at delivery were significantly more likely to experience maternal adverse events (OR 3.896, 95% CI 1.339-11.337).

also in 1,506 other papers